Sagopilone

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameSagopilone
Drug Alias Name沙戈匹隆SagopilonaSagopilonumSHY-03757ZK-epothilone +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulatorsTubulin polymerisation promoters
TargetsTubulin
Therapy Area/IndicationsMetastatic breast cancerCentral Nervous System DiseasesProstatic Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[15] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoires Thissen SaH Lee Moffitt Cancer Center & Research InstituteSchering Ag +[5] 
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerCentral Nervous System DiseasesProstatic Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksKEGG